
The WHO Science Division conducted a horizon scan exercise to identify new and emerging innovations in science and technology that could significantly impact global health in the future. The article invites readers to consider the innovations from a public health perspective and to assess their potential benefits and risks.
Recent Posts

Orphan Drug Designation Zoci Enhances Treatment Prospects for Pulmonary Neuroendocrine Carcinomas
The European Medicines Agency has granted orphan drug designation for zocilurtatug pelitecan, an investigational DLL3-targeted antibody-drug conjugate, based on ...

Belgium Fast Access Medicines Revolutionize Treatment for IgA Nephropathy
Belgium Fast Access Medicines has moved from policy to practice. Authorities have granted temporary reimbursement to Atrasentan, the first therapy approved under the new Early and Equitable Fast Access procedure, offering quicker hope to patients with IgA nephropathy while anchoring the country’s...

Retracted Trial Publication Undermines Support for Avacopan in AAV Treatment
The Retracted Trial Publication of the ADVOCATE study has eliminated the central evidence that supported approval of Tavneos (avacopan) for severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (AAV). At the request of two lead academic authors, the